Platelet activation: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Bruce M. Tindall m (Insignificant change to force appearance in appropriate category lists) |
||
| Line 6: | Line 6: | ||
Platelet activation is inhibited for medical purposes by drugs called [[platelet aggregation inhibitor]]s. | Platelet activation is inhibited for medical purposes by drugs called [[platelet aggregation inhibitor]]s. | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 15:20, 7 May 2008
Platelet activation is a "series of progressive, overlapping events, triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug."[1]
Platelet activation, along with coagulation, leads to hemostasis.
Platelet activation is inhibited for medical purposes by drugs called platelet aggregation inhibitors.
References
- ↑ Anonymous (2024), Platelet activation (English). Medical Subject Headings. U.S. National Library of Medicine.